FRESENIUS MEDICAL CA
FME
 Delayed - 07/01 11:35:00 am |
|
| 47.58EUR | -0.10% |
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS maintains a Buy rating
06/23/2022 | 07:12am
|
In his latest research note, analyst Graham Doyle confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price remains unchanged at EUR 75.
© MarketScreener with dpa-AFX Analyser 2022
|
|
|
|
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
